ESE vs SYRE

Comparison between Esco Technologies Inc (ESE, Company) and Spyre Therapeutics Inc (SYRE, Company).

ESE is from the Technology sector, while SYRE is from the Healthcare sector.

5-Year PerformanceESE has outperformed SYRE, delivering a return of +27.3% compared to -7.9%

ESE vs SYRE - Performance Comparison

Log

Key Characteristics

Financial metrics and valuation ratios

Metric	ESE(COMPANY)	SYRE(COMPANY)
Market Cap	$7.77B	$7.72B
Max Drawdown	57.84%	99.11%
Sharpe Ratio	1.50	2.88
5Y Beta	1.03	1.76
Industry	Scientific & Technical Instruments	Biotechnology
P/E Ratio	64.34	-39.65
Forward P/E	25.38	N/A
PEG Ratio	2.02	N/A
Dividend Yield	0.10%	N/A
5Y Dividends CAGR	4.56%	N/A
5Y EPS CAGR	9.96%	-2.15%
Debt to Equity	9.15%	0.00%
Free Cash Flow Yield	3.33%	-2.41%
P/S Ratio	6.23	650.22
P/B Ratio	5.16	16.86

Market Cap

Winner

ESE

$7.77B

SYRE

$7.72B

Max Drawdown

Winner

ESE

57.84%

SYRE

99.11%

Sharpe Ratio

ESE

1.50

Winner

SYRE

2.88

5Y Beta

Winner

ESE

1.03

SYRE

1.76

Industry

ESE

Scientific & Technical Instruments

SYRE

Biotechnology

P/E Ratio

ESE

64.34

Winner

SYRE

-39.65

Forward P/E

ESE

25.38

SYRE

N/A

PEG Ratio

ESE

2.02

SYRE

N/A

Dividend Yield

ESE

0.10%

SYRE

N/A

5Y Dividends CAGR

ESE

4.56%

SYRE

N/A

5Y EPS CAGR

Winner

ESE

9.96%

SYRE

-2.15%

Debt to Equity

ESE

9.15%

Winner

SYRE

0.00%

Free Cash Flow Yield

Winner

ESE

3.33%

SYRE

-2.41%

P/S Ratio

Winner

ESE

6.23

SYRE

650.22

P/B Ratio

Winner

ESE

5.16

SYRE

16.86

ESE vs SYRE - Historical Returns

Returns include dividend reinvestment.

Period	ESE	SYRE
1 month	-10.99%	+14.33%
3 months	-3.82%	+36.33%
6 months	+36.60%	+217.39%
1 year	+59.62%	+487.04%
5 years(CAGR)	+27.35%	-7.91%
10 years(CAGR)	+22.54%	-1.66%
Max(CAGR)	+16.46%	-8.16%

ESE

-10.99%

Winner

SYRE

+14.33%

ESE

-3.82%

Winner

SYRE

+36.33%

ESE

+36.60%

Winner

SYRE

+217.39%

ESE

+59.62%

Winner

SYRE

+487.04%

5Y(CAGR)

Winner

ESE

+27.35%

SYRE

-7.91%

10Y(CAGR)

Winner

ESE

+22.54%

SYRE

-1.66%

Max(CAGR)

Winner

ESE

+16.46%

SYRE

-8.16%

ESE vs SYRE - Annual Returns (1999 - 2026)

Returns include dividend reinvestment.

Year	ESE	SYRE
2026	+57.71%	+231.92%
2025	+48.74%	+37.36%
2024	+16.00%	+8.79%
2023	+34.96%	+104.27%
2022	-0.93%	-90.57%
2021	-9.76%	-44.51%
2020	+11.04%	+1.55%
2019	+43.31%	-4.98%
2018	+10.04%	+39.22%
2017	+5.48%	+18.38%
2016	+62.15%	-55.48%
2015	+0.56%	N/A
2014	+9.67%	N/A
2013	-9.42%	N/A
2012	+28.95%	N/A
2011	-24.91%	N/A
2010	+3.99%	N/A
2009	-15.18%	N/A
2008	+6.34%	N/A
2007	-9.84%	N/A
2006	-0.13%	N/A
2005	+19.63%	N/A
2004	+74.20%	N/A
2003	+18.58%	N/A
2002	+10.94%	N/A
2001	+74.10%	N/A
2000	+78.98%	N/A
1999	-0.51%	N/A

ESE vs SYRE Drawdown Comparison

The maximum drawdown for ESE was -57.13%, occurring on Oct 3, 2011. Recovery took 2582 trading sessions.

The maximum drawdown for SYRE was -99.11%, occurring on Jun 21, 2023. This drawdown has not yet recovered.

The current ESE drawdown is -12.20%. The current SYRE drawdown is -66.14%.

Rank	ESE	SYRE
#1	-57.13% Aug 16, 2006 - Nov 16, 2016	-99.11% Apr 8, 2016 - Jun 21, 2023
#2	-45.96% Mar 19, 2021 - Dec 14, 2023	N/A
#3	-36.20% Feb 12, 2020 - Dec 15, 2020	N/A
#4	-35.46% Aug 12, 2005 - May 4, 2006	N/A
#5	-34.66% May 1, 2002 - May 30, 2003	N/A
#6	-31.03% Jun 1, 2001 - Dec 5, 2001	N/A
#7	-18.61% Nov 5, 1999 - Dec 6, 1999	N/A
#8	-18.61% Jul 20, 2017 - Nov 21, 2017	N/A
#9	-18.26% Sep 9, 2003 - May 3, 2004	N/A
#10	-17.52% Feb 20, 2025 - May 8, 2025	N/A
#11	-17.39% Dec 27, 2023 - Jul 16, 2024	N/A
#12	-16.55% Jul 6, 2000 - Dec 28, 2000	N/A
#13	-16.54% Jan 16, 2018 - Aug 14, 2018	N/A
#14	-15.57% May 5, 2006 - Aug 15, 2006	N/A
#15	-15.48% Mar 4, 2005 - May 18, 2005	N/A

Correlation

Correlation between ESE and SYRE is -0.43 which considered as a weak negative correlation - the stocks show a slight tendency to move in opposite directions.

-0.43

-101